Exploring new bioprocess considerations for cardiomyogenesis of embryonic stem cells
Ex vivo cardiomyocytes production from pluripotent stem cells is highly attractive as a future clinical therapy for cardiovascular diseases. Scaled-up 3-dimensional cell culture can be used to produce clinically relevant cell numbers but requires numerous bioprocess design considerations. In this th...
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | |
| פורמט: | Thesis |
| שפה: | English |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://hdl.handle.net/10356/61818 |